The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfilER Study.
 
Olivier Tredan
Research Funding - Bayer; GlaxoSmithKline; Novartis
 
Veronique Corset
No Relationships to Disclose
 
Qing Wang
No Relationships to Disclose
 
Romain Varnier
No Relationships to Disclose
 
Camille Pacaud
No Relationships to Disclose
 
Alexia Torroja
No Relationships to Disclose
 
Nicolas Luppi
No Relationships to Disclose
 
Monia Ezzalfani
No Relationships to Disclose
 
Magali Myard
No Relationships to Disclose
 
Xiaojun Jiang
No Relationships to Disclose
 
Valéry Attignon
No Relationships to Disclose
 
Daniel Pissaloux
No Relationships to Disclose
 
Christian Baudet
No Relationships to Disclose
 
Philippe Alexandre Cassier
Honoraria - Amgen; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
 
Jérôme Fayette
Leadership - Glycotope GmbH
Honoraria - AstraZeneca; Bristol-Myers Squibb
 
Mélodie Carbonnaux
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Alice Bonneville-Levard
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Alain Viari
No Relationships to Disclose
 
David Pérol
Honoraria - Celgene; Janssen; Lilly; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Jean-Yves Blay
Research Funding - Bayer; GlaxoSmithKline; Novartis